Chemoradiation-induced cell loss in human submandibular glands

Laryngoscope

Volumn 115, Issue 6, 2005, Pages 958-964

  Sullivan, Christopher A ^a,e   Haddad, Robert I ^b   Tishler, Roy B ^b   Mahadevan, Anand ^c   Krane, Jeffrey F ^d  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Chemoradiation; Submandibular gland; Xerostomia

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTOKERATIN; DOCETAXEL; FLUOROURACIL;

ACINAR CELL; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CELL LOSS; CELL PROLIFERATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; NECK DISSECTION; PRIORITY JOURNAL; RADIATION DOSE; SUBMANDIBULAR GLAND; XEROSTOMIA;

AGED; COMBINED MODALITY THERAPY; FEMALE; FIBROSIS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; NECK DISSECTION; SUBMANDIBULAR GLAND; XEROSTOMIA;

EID: 20144377609     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MLG.0000163340.90211.87     Document Type: Article

References (14)

1. Bergonie J. Sur quelques formes de reactions precoces après des irradiations. Arch Elect Med 1911;19:241-245.
2. Brizel DM, Wassweman TH, Henka M. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clinical Oncol 2000;18:3339-3345.
3. Abok K, Brunk U, Jung B, Ericsson J. Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland. Virchows Arch B Cell Pathol 1984;45:443-460.
4. Dreyer JO, Sakuma Y, Seifert G. Die Strahlensialadenitis: Stadieneinteilung und Immunhistologie. Pathologe 1989;10:165-170.
5. Nagler RM, Baum BJ. Prophylactic treatment reduces the severity of xerostomia following radiation therapy for oral cavity cancer. Arch Otolaryngol Head Neck Surg 2003;129:247-250.
6. Drezen S, Brown LR, Handler S, Levy BM. Radiation induced xerostomia in cancer patients. Cancer 1976;38:273-278.
7. Mossmann K, Shatzman A, Chencharik J. Quantitative dose-response relationships of the salivary glands during radiotherapy. Radiat Res 1983;95:392-398.
8. Stephens LC, King GK, Peters LJ, Ang KK, Schulteiss TM, Jardine JH. Unique radiosensitivity of serous cells in rhesus monkey submandibular glands. Am J Pathol 1986;124:479-487.
9. Bartel-Friedrich S, Friedrich RE, Lautenschlager C, et al. Dose-response relationships on the expression profile of cytokeratins and vimentin in rat submandibular glands following fractionated irradiation. Anticancer Research 2000;20:4917-4926.
10. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002;40:2-11.
11. Ihrler S, Zietz C, Sendelhofert A, et al. A morphogenetic concept of salivary duct regeneration and metaplasia. Virchows Arch 2002;440:519-526.
12. Pellegrini G, Dellambra E, Golisano O, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 2001;98:3156-3161.
13. Bilal H, Handra-Luca A, Bertrand JC, Fouret PJ. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 2003;51:133-139.
14. Barbareschi M, Pecciarini L, Cangi MG, et al. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054-1060.